| From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors RL Wahl, H Jacene, Y Kasamon, MA Lodge Journal of nuclear medicine 50 (Suppl 1), 122S-150S, 2009 | 3633 | 2009 |
| American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer GH Lyman, AE Giuliano, MR Somerfield, AB Benson III, DC Bodurka, ... Journal of clinical oncology 23 (30), 7703-7720, 2005 | 2258 | 2005 |
| Recommendations on the use of 18F-FDG PET in oncology JW Fletcher, B Djulbegovic, HP Soares, BA Siegel, VJ Lowe, GH Lyman, ... Journal of Nuclear Medicine 49 (3), 480-508, 2008 | 1227 | 2008 |
| Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants PD Shreve, Y Anzai, RL Wahl Radiographics 19 (1), 61-77, 1999 | 1030 | 1999 |
| Metastases from non-small cell lung cancer: mediastinal staging in the 1990s—meta-analytic comparison of PET and CT BA Dwamena, SS Sonnad, JO Angobaldo, RL Wahl Radiology 213 (2), 530-536, 1999 | 905 | 1999 |
| 131I-tositumomab therapy as initial treatment for follicular lymphoma MS Kaminski, M Tuck, J Estes, A Kolstad, CW Ross, K Zasadny, D Regan, ... New England Journal of Medicine 352 (5), 441-449, 2005 | 858 | 2005 |
| Radioimmunotherapy of B-cell lymphoma with [131I] anti-B1 (anti-CD20) antibody MS Kaminski, KR Zasadny, IR Francis, AW Milik, CW Ross, SD Moon, ... New England Journal of Medicine 329 (7), 459-465, 1993 | 770 | 1993 |
| Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. KR Zasadny, RL Wahl Radiology 189 (3), 847-850, 1993 | 751 | 1993 |
| Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation. RL Wahl, K Zasadny, M Helvie, GD Hutchins, B Weber, R Cody Journal of Clinical Oncology 11 (11), 2101-2111, 1993 | 745 | 1993 |
| Dynamic imaging of allogeneic mesenchymal stem cells trafficking to myocardial infarction DL Kraitchman, M Tatsumi, WD Gilson, T Ishimori, D Kedziorek, ... Circulation 112 (10), 1451-1461, 2005 | 742 | 2005 |
| Overexpression of glut‐1 glucose transporter in human breast cancer an immunohistochemical study RS Brown, RL Wahl Cancer 72 (10), 2979-2985, 1993 | 720 | 1993 |
| Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin’s lymphomas MS Kaminski, AD Zelenetz, OW Press, M Saleh, J Leonard, ... Journal of clinical oncology 19 (19), 3918-3928, 2001 | 709 | 2001 |
| Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin’s lymphomas MS Kaminski, AD Zelenetz, OW Press, M Saleh, J Leonard, ... Journal of clinical oncology 19 (19), 3918-3928, 2001 | 709 | 2001 |
| Radioimmunotherapy with iodine 131I tositumomab for relapsed or refractory B-cell non-Hodgkin lymphoma: updated results and long-term follow-up of the … MS Kaminski, J Estes, KR Zasadny, IR Francis, CW Ross, M Tuck, ... Blood, The Journal of the American Society of Hematology 96 (4), 1259-1266, 2000 | 641 | 2000 |
| Demonstration of accuracy and clinical versatility of mutual information for automatic multimodality image fusion using affine and thin-plate spline warped geometric deformations CR Meyer, JL Boes, B Kim, PH Bland, KR Zasadny, PV Kison, K Koral, ... Medical image analysis 1 (3), 195-206, 1997 | 634 | 1997 |
| Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: preliminary prospective evaluation. RL Wahl, LE Quint, RL Greenough, CR Meyer, RI White, MB Orringer Radiology 191 (2), 371-377, 1994 | 573 | 1994 |
| Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized … F Pacini, PW Ladenson, M Schlumberger, A Driedger, M Luster, RT Kloos, ... The Journal of Clinical Endocrinology & Metabolism 91 (3), 926-932, 2006 | 568 | 2006 |
| Uptake in supraclavicular area fat (“USA-Fat”): description on 18F-FDG PET/CT C Cohade, M Osman, HK Pannu, RL Wahl Journal of Nuclear Medicine 44 (2), 170-176, 2003 | 549 | 2003 |
| Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose. RL Wahl, RL Cody, GD Hutchins, EE Mudgett Radiology 179 (3), 765-770, 1991 | 542 | 1991 |
| Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma. MS Kaminski, KR Zasadny, IR Francis, MC Fenner, CW Ross, AW Milik, ... Journal of Clinical Oncology 14 (7), 1974-1981, 1996 | 539 | 1996 |
Martin A. LodgeProfessor of Radiology and Radiological Science, Johns Hopkins UniversityVerified email at jhmi.edu
